HB 533 substantially revises Florida’s naturopathy law by redesignating chapter 462 as “Naturopathic Medicine” and creating a new, more detailed licensing and regulatory framework for naturopathic physicians. The bill states legislative findings that naturopathic medicine is a distinct health care profession and sets out the chapter’s purpose: to protect public health, safety, and welfare while ensuring access to qualified naturopathic physicians. It creates a new Board of Naturopathic Medicine within the Department of Health, establishes board membership requirements, and requires disciplinary training for board members before they may participate in probable cause panels or disciplinary decisions.
The bill creates or revises core licensure provisions, including licensure by examination and endorsement, renewal, inactive status, reactivation, continuing education, and recordkeeping rules. It defines the scope of naturopathic medicine, the titles and credentials that may be used, and the activities that remain prohibited, such as surgery, anesthesia, and practice outside the authorized scope. It also adds rules for patient records, specialty advertising, and patient disclosure of prescribed legend drugs, nutrients, or natural medicinal substances to other health care practitioners.
A major feature of the bill is its financial responsibility requirement. Licensed naturopathic physicians generally must maintain malpractice coverage, an escrow account, or a letter of credit, with limited exemptions for certain government, teaching, inactive, or long-practicing part-time physicians. The bill requires notice to patients when a physician qualifies for an exemption and chooses not to carry malpractice insurance, and it authorizes suspension or discipline for noncompliance, unpaid judgments, or deceptive statements about exemption status.
The bill also expands and reorganizes disciplinary authority. It revises grounds for discipline, sets evidentiary standards for administrative actions, requires rules for disciplinary guidelines, and authorizes the department to investigate closed claims and incident reports. It adds criminal penalties for unlicensed practice and other violations, and it updates numerous cross-references in other Florida statutes so naturopathic physicians are recognized in public health reporting, insurance, controlled substances, and related regulatory provisions.
Overall, the bill appears to be a comprehensive modernization and expansion of the state’s naturopathic medicine laws, with a strong emphasis on formal licensure, consumer disclosure, malpractice accountability, and clearer enforcement authority. No committee transcripts or recorded votes were provided, so there is no documented legislative debate or voting history in the supplied materials.
HB 533 would significantly amend chapter 462 and related statutes by replacing the older “naturopathy” framework with a more detailed “naturopathic medicine” regulatory scheme. It creates a new board, expands licensure and discipline provisions, imposes continuing education and financial responsibility requirements, and updates cross-references across Florida law to include naturopathic physicians in areas such as public health reporting, insurance, controlled substances, and criminal penalties for unlicensed practice. The bill would affect applicants, licensed naturopathic physicians, patients, insurers, and the Department of Health.
Based on the bill text alone, the measure appears generally supportive of naturopathic medicine and its formal recognition as a regulated health profession, while also emphasizing consumer protection and professional accountability. Because no committee transcripts or votes were provided, there is no recorded public debate in the supplied materials to indicate opposition or support from specific lawmakers or stakeholders. The structure of the bill suggests an intent to legitimize and standardize the profession rather than restrict it.
The most likely points of contention are the scope of practice, especially the inclusion of prescriptive rights and the use of legend drugs, and the creation of a separate board and licensing regime for naturopathic physicians. Malpractice insurance and financial responsibility requirements may also be controversial, particularly the exemptions for certain experienced or part-time practitioners and the required patient notice when a physician does not carry insurance. Additional friction could arise over disciplinary authority, title protection, and the bill’s treatment of traditional naturopaths versus licensed naturopathic physicians.